Xinxiang Tuoxin Pharmaceutical (301089) Stock Overview

Tuoxin Pharmaceutical Group Co.,Ltd. engages in the research, development, production, and sale of chemical synthesis, biological fermentation nucleoside (acid) APIs, and pharmaceutical intermediates in China and internationally. It offers purine base, pyrimidine base, nucleosides, nucleotide, deoxynucleosides, dehyfrated nucleoside, 2'-modified, Cybinucleoside, and sugar series, and Azvudine intermediate. The company also provides Disodium 5'-cytidylate, Disodium 5'-uridylate, 5'-Adenosine monophosphate, and D-ribose, as well as citicoline sodium, ribavir Lin, inosine, acyclovir, cytosine, 5-fluorocytosine, cytidine, and other APIs and pharmaceutical intermediates. The company was founded in 2001 and is based in Xinxiang, China.